Cerebral Amyloid Angiopathy

Stroke: Pathophysiology, Diagnosis, and Management

Volumn , Issue , 2004, Pages 693-705

  Greenberg, Steven M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942583333     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-44-306600-0/50039-0     Document Type: Chapter

References (164)

1. Greenberg SM, Vonsattel J-PG Diagnosis of cerebral amyloid angiopathy: Sensitivity and specificity of cortical biopsy. Stroke 1997, 28:1418.
2. Brott T, Thalinger K, Hertzberg V Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke 1986, 17:1078.
3. Broderick JP, Brott T, Tomsick T, et al. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med 1992, 326:733.
4. Schutz H, Bodeker RH, Damian M, et al. Age-related spontaneous intracerebral hematoma in a German community. Stroke 1990, 21:1412.
5. Itoh Y, Yamada M, Hayakawa M, et al. Cerebral amyloid angiopathy: A significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci 1993, 116:135.
6. Lee SS, Stemmermann GN Congophilic angiopathy and cerebral hemorrhage. Arch Pathol Lab Med 1978, 102:317.
7. Tomonaga M Cerebral amyloid angiopathy in the elderly. J Am Geriatr Soc 1981, 29:151.
8. Vinters HV, Gilbert JJ Cerebral amyloid angiopathy: Incidence and complications in the aging brain. II: The distribution of amyloid vascular changes. Stroke 1983, 14:924.
9. Masuda J, Tanaka K, Ueda K, et al. Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan. Stroke 1988, 19:205.
10. Jellinger K Cerebrovascular amyloidosis with cerebral hemorrhage. J Neurol 1977, 214:195.
11. Vinters HV Cerebral amyloid angiopathy: A critical review. Stroke 1987, 18:311.
12. Ellis RJ, Olichney JM, Thal LJ, et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience, Part XV. Neurology 1996, 46:1592.
13. Mandybur TI Cerebral amyloid angiopathy: The vascular pathology and complications. J Neuropathol Exp Neurol 1986, 45:79.
14. Greenberg SM, Briggs ME, Hyman BT, et al. Apolipoprotein E e4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke 1996, 27:1333.
15. Fisher CM Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol 1971, 30:536.
16. Bahemuka M Primary intracerebral hemorrhage and heart weight: A clinicopathologic case-control review of 218 patients. Stroke 1987, 18:531.
17. Massaro AR, Sacco RL, Mohr JP, et al. Clinical discriminators of lobar and deep hemorrhages: The Stroke Data Bank. Neurology 1991, 41:1881.
18. Broderick J, Brott T, Tomsick T, et al. Lobar hemorrhage in the elderly: The undiminishing importance of hypertension. Stroke 1993, 24:49.
19. Thrift AG, McNeil JJ, Forbes A, et al. Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage. Melbourne Risk Factor Study Group. Hypertension 1998, 31:1223.
20. O'Donnell HC, Rosand J, Knudsen KA, et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 2000, 342:240.
21. Ferreiro JA, Ansbacher LE, Vinters HV Stroke related to cerebral amyloid angiopathy: The significance of systemic vascular disease. J Neurol 1989, 236:267.
22. Woo D, Sauerbeck LR, Kissela BM, et al. Genetic and environmental risk factors for intracerebral hemorrhage: Preliminary results of a population-based study. Stroke 2002, 33:1190.
23. Tanaka H, Ueda Y, Hayashi M, et al. Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke 1982, 13:62.
24. Iso H, Jacobs DJ, Wentworth D, et al. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial [see comments]. N Engl J Med 1989, 320:904.
25. Yano K, Reed DM, MacLean CJ Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. Stroke 1989, 20:1460.
26. Gatchev O, Rastam L, Lindberg G, et al. Subarachnoid hemorrhage, cerebral hemorrhage, and serum cholesterol concentration in men and women. Ann Epidemiol 1993, 3:403.
27. Lindenstrom E, Boysen G, Nyboe J Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: The Copenhagen City Heart Study [see comments]. BMJ 1994, 309:1619.
28. Iribarren C, Jacobs DR, Sadler M, et al. Low total serum cholesterol and intracerebral hemorrhagic stroke: Is the association confined to elderly men?. Stroke 1996, 27:1993.
29. Giroud M, Creisson E, Fayolle H, et al. Risk factors for primary cerebral hemorrhage: A population-based study. The Stroke Registry of Dijon. Neuroepidemiology 1995, 14:20.
30. Segal AZ, Chiu RI, Eggleston-Sexton PM, et al. Low cholesterol as a risk factor for primary intracerebral hemorrhage: A case-control study. Neuroepidemiology 1999, 18:185.
31. Vonsattel JP, Myers RH, Hedley-Whyte ET, et al. Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study. Ann Neurol 1991, 30:637.
32. Yamada M, Itoh Y, Shintaku M, et al. Immune reactions associated with cerebral amyloid angiopathy. Stroke 1996, 27:1155.
33. Maat-Schieman ML, van Duinen SG, Rozemuller AJ, et al. Association of vascular amyloid beta and cells of the mononuclear phagocyte system in hereditary cerebral hemorrhage with amyloidosis (Dutch) and Alzheimer disease. J Neuropathol Exp Neurol 1997, 56:273.
34. Uchihara T, Akiyama H, Kondo H, et al. Activated microglial cells are colocalized with perivascular deposits of amyloid-beta protein in Alzheimer's disease brain. Stroke 1997, 28:1948.
35. Vinters HV, Natte R, Maat-Schieman ML, et al. Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D). Acta Neuropathol 1998, 95:235.
36. Maeda A, Yamada M, Itoh Y, et al. Computer-assisted three-dimensional image analysis of cerebral amyloid angiopathy. Stroke 1993, 24:1857.
37. Natte R, Vinters HV, Maat-Schieman ML, et al. Microvasculopathy is associated with the number of cerebrovascular lesions in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Stroke 1998, 29:1588.
38. McCarron MO, Nicoll JA, Stewart J, et al. The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol 1999, 58:711.
39. Jarrett JT, Berger EP, Lansbury PT The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993, 32:4693.
40. Shinkai Y, Yoshimura M, Ito Y, et al. Amyloid β-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels. Ann Neurol 1995, 38:421.
41. Natte R, Yamaguchi H, Maat-Schieman ML, et al. Ultrastructural evidence of early non-fibrillar Abeta42 in the capillary basement membrane of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type. Acta Neuropathol (Berl) 1999, 98:577.
42. Iwatsubo T, Odaka A, Suzuki N, et al. Visualization of A beta 4243) and A beta 40 in senile plaques with end-specific A beta monoclonals: Evidence that an initially deposited species is A beta 42(43). Neuron 1994, 13:45.
43. Mak K, Yang F, Vinters HV, et al. Polyclonals to beta-amyloid(1-42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum. Brain Res 1994, 667:138.
44. Gravina SA, Ho LB, Eckman CB, et al. Amyloid beta protein (a-beta) in Alzheimer's disease brain: Biochemical and immunocytochemical analysis with antibodies specific for forms ending at a-beta-40 or a-beta-42(43). J Biol Chem 1995, 270:7013.
45. Iwatsubo T, Mann DM, Odaka A, et al. Amyloid beta protein (A beta) deposition: A beta 42:43 precedes A beta 40 in Down syndrome. Ann Neurol 1995, 37:294.
46. Lemere CA, Blusztajn JK, Yamaguchi H, et al. Sequence of deposition of heterogeneous amyloid β-peptides and APO E in Down syndrome: Implications for initial events in amyloid plaque formation. Neurobiol Dis 1996, 3:16.
47. Castano EM, Prelli F, Soto C, et al. The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type: Implications for the role of amyloid-beta 1-42 in Alzheimer's disease. J Biol Chem 1996, 271:32185.
48. Mann DM, Iwatsubo T, Ihara Y, et al. Predominant deposition of amyloid-beta 4243 in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am J Pathol 1996, 148:1257.
49. Alonzo NC, Hyman BT, Rebeck GW, et al. Progression of cerebral amyloid angiopathy: Accumulation of amyloidβ40 in already affected vessels. J Neuropathol Exp Neurol 1998, 57:353.
50. Snow AD, Mar H, Nochlin D, et al. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am J Pathol 1990, 137:1253.
51. Vinters HV, Nishimura GS, Secor DL, et al. Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease. Am J Pathol 1990, 137:233.
52. Namba Y, Tomonaga M, Kawasaki H, et al. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991, 541:163.
53. Kalaria RN, Kroon SN Complement inhibitor C4-binding protein in amyloid deposits containing serum amyloid P in Alzheimer's disease. Biochem Biophys Res Commun 1992, 186:461.
54. Ueda K, Fukushima H, Masliah E, et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci U S A 1993, 90:11282.
55. Verbeek MM, Eikelenboom P, de Waal RM Differences between the pathogenesis of senile plaques and congophilic angiopathy in Alzheimer disease. J Neuropathol Exp Neurol 1997, 56:751.
56. Cho HS, Hyman BT, Greenberg SM, et al. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation. J Neuropathol Exp Neurol 2001, 60:342.
57. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A 1993, 90:9649.
58. Greenberg SM, Rebeck GW, Vonsattel JPV, et al. Apolipoprotein E e4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995, 38:254.
59. Premkumar DR, Cohen DL, Hedera P, et al. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 1996, 148:2083.
60. Olichney JM, Hansen LA, Galasko D, et al. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 1996, 47:190.
61. Greenberg SM, Vonsattel JP, Segal AZ, et al. Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology 1998, 50:961.
62. Davis J, Van Nostrand WE Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein. Proc Natl Acad Sci U S A 1996, 93:2996.
63. Verbeek MM, de Waal RM, Schipper JJ, et al. Rapid degeneration of cultured human brain pericytes by amyloid beta protein. J Neurochem 1997, 68:1135.
64. Wang Z, Natte R, Berliner JA, et al. Toxicity of dutch (E22Q) and flemish (A21G) mutant amyloid beta proteins to human cerebral microvessel and aortic smooth muscle cells. Stroke 2000, 31:534.
65. Eisenhauer PB, Johnson RJ, Wells JM, et al. Toxicity of various amyloid beta peptide species in cultured human blood-brain barrier endothelial cells: Increased toxicity of Dutch-type mutant. J Neurosci Res 2000, 60:804.
66. Melchor JP, McVoy L, Van Nostrand WE Charge alterations of E22 enhance the pathogenic properties of the amyloid beta-protein. J Neurochem 2000, 74:2209.
67. Miravalle L, Tokuda T, Chiarle R, et al. Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J Biol Chem 2000, 275:27110.
68. Van Nostrand WE, Melchor JP, Cho HS, et al. Pathogenic effects of D23N Iowa mutant amyloid beta-protein. J Biol Chem 2001, 276:32860.
69. Van Nostrand WE, Melchor JP, Ruffini L Pathologic amyloid beta-protein cell surface fibril assembly on cultured human cerebrovascular smooth muscle cells. J Neurochem 1998, 70:216.
70. Melchor JP, Van Nostrand WE Fibrillar amyloid beta-protein mediates the pathologic accumulation of its secreted precursor in human cerebrovascular smooth muscle cells. J Biol Chem 2000, 275:9782.
71. Kingston IB, Castro MJ, Anderson S In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid beta-peptide analogues. Nature Medicine 1995, 1:138.
72. Van Nostrand WE, Porter M Plasmin cleavage of the amyloid beta-protein: Alteration of secondary structure and stimulation of tissue plasminogen activator activity. Biochemistry 1999, 38:11570.
73. Calhoun ME, Burgermeister P, Phinney AL, et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci U S A 1999, 96:14088.
74. Van Dorpe J, Smeijers L, Dewachter I, et al. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons. Am J Pathol 2000, 157:1283.
75. Kimchi EY, Kajdasz S, Bacskai BJ, et al. Analysis of cerebral amyloid angiopathy in a transgenic mouse model of Alzheimer disease using in vivo multiphoton microscopy. J Neuropathol Exp Neurol 2001, 60:274.
76. Christie R, Yamada M, Moskowitz M, et al. Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy. Am J Pathol 2001, 158:1065.
77. Winkler DT, Bondolfi L, Herzig MC, et al. Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. J Neurosci 2001, 21:1619.
78. Weller RO, Massey A, Newman TA, et al. Cerebral amyloid angiopathy: Amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol 1998, 153:725.
79. Wyss-Coray T, Masliah E, Mallory M, et al. Amyloidogenic role of cytokine TGFβ1 in transgenic mice and in Alzheimer's disease. Nature 1997, 389:603.
80. Wyss-Coray T, Lin C, Yan F, et al. TGF-betal promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nature Med 2001, 7:612.
81. Iadecola C, Zhang F, Niwa K, et al. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci 1999, 2:157.
82. Niwa K, Younkin L, Ebeling C, et al. Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc Natl Acad Sci U S A 2000, 97:9735.
83. Thomas T, Thomas G, McLendon C, et al. beta-amyloid-mediated vasoactivity and vascular endothelial damage. Nature 1996, 380:168.
84. Gilbert JJ, Vinters HV Cerebral amyloid angiopathy: Incidence and complications in the aging brain. I: Cerebral hemorrhage. Stroke 1983, 14:915.
85. Yamada M, Itoh Y, Otomo E, et al. Subarachnoid haemorrhage in the elderly: A necropsy study of the association with cerebral amyloid angiopathy. J Neurol Neurosurg Psychiatry 1993, 56:543.
86. Miller JH, Wardlaw JM, Lammie GA Intracerebral haemorrhage and cerebral amyloid angiopathy: CT features with pathological correlation. Clin Radiol 1999, 54:422.
87. Ohshima T, Endo T, Nukui H, et al. Cerebral amyloid angiopathy as a cause of subarachnoid hemorrhage. Stroke 1990, 21:480.
88. Kase CS Lobar hemorrhage. Intracerebral Hemorrhage 1994, 363. Butterworth-Heinemann, Boston. C.S. Kase, L.R. Caplan (Eds.).
89. Okazaki H, Reagan TJ, Campbell RJ Clinicopathologic studies of primary cerebral amyloid angiopathy. Mayo Clin Proc 1979, 54:22.
90. Atlas SW, Mark AS, Grossman RI, et al. Intracranial hemorrhage: Gradient-echo MR imaging at 1.5 T. Comparison with spin-echo imaging and clinical applications. Radiology 1988, 168:803.
91. Greenberg SM, Finklestein SP, Schaefer PW Petechial hemorrhages accompanying lobar hemorrhages: Detection by gradient-echo MRI. Neurology 1996, 46:1751.
92. Fazekas F, Kleinert R, Roob G, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: Evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 1999, 20:637.
93. Tsushima Y, Tamura T, Unno Y, et al. Multifocal low-signal brain lesions on T2*-weighted gradient-echo imaging. Neuroradiology 2000, 42:499.
94. Knudsen KA, Rosand J, Karluk D, et al. Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston criteria. Neurology 2001, 56:537.
95. Hart RG, Boop BS, Anderson DC Oral anticoagulants and intracranial hemorrhage: Facts and hypotheses. Stroke 1995, 26:1471.
96. Ramsay DA, Penswick JL, Robertson DM Fatal streptokinase-induced intracerebral haemorrhage in cerebral amyloid angiopathy. Can J Neurol Sci 1990, 17:336.
97. Leblanc R, Haddad G, Robitaille Y Cerebral hemorrhage from amyloid angiopathy and coronary thrombolysis. Neurosurgery 1992, 31:586.
98. Wijdicks EF, Jack CRJ Intracerebral hemorrhage after fibrinolytic therapy for acute myocardial infarction. Stroke 1993, 24:554.
99. Melo TP, Bogousslavsky J, Regli F, et al. Fatal hemorrhage during anticoagulation of cardioembolic infarction: Role of cerebral amyloid angiopathy. Eur Neurol 1993, 33:9.
100. Sloan MA, Price TR, Petito CK, et al. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: The Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience. Neurology 1995, 45:649.
101. Rosand J, Hylek EM, O'Donnell HC, et al. Warfarin-associated hemorrhage and cerebral amyloid angiopathy: A genetic and pathologic study. Neurology 2000, 55:947.
102. Anderson JL, Karagounis L, Allen A, et al. Older age and elevated blood pressure are risk factors for intracerebral hemorrhage after thrombolysis. Am J Cardiol 1991, 68:166.
103. De Jaegere PP, Arnold AA, Balk AH, et al. Intracranial hemorrhage in association with thrombolytic therapy: Incidence and clinical predictive factors. J Am Coll Cardiol 1992, 19:289.
104. Hylek EM, Singer DE Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994, 120:897.
105. Bleeding during antithrombotic therapy in patients with atrial fibrillation The Stroke Prevention in Atrial Fibrillation Investigators. Arch Intern Med 1996, 156:409.
106. Gray F, Dubas F, Roullet E, et al. Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann Neurol 1985, 18:54.
107. Olichney JM, Hansen LA, Hofstetter CR, et al. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 1995, 52:702.
108. Cadavid D, Mena H, Koeller K, et al. Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction: A case control study in human brain biopsies. J Neuropathol Exp Neurol 2000, 59:768.
109. Greenberg SM, Vonsattel JP, Stakes JW, et al. The clinical spectrum of cerebral amyloid angiopathy: Presentations without lobar hemorrhage. Neurology 1993, 43:2073.
110. Silbert PL, Bartleson JD, Miller GM, et al. Cortical petechial hemorrhage, leukoencephalopathy, and subacute dementia associated with seizures due to cerebral amyloid angiopathy. Mayo Clin Proc 1995, 70:477.
111. Bornebroek M, Haan J, van Buchem MA, et al. White matter lesions and cognitive deterioration in presymptomatic carriers of the amyloid precursor protein gene codon 693 mutation. Arch Neurol 1996, 53:43.
112. Grabowski TJ, Cho HS, Vonsattel JPG, et al. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 2001, 49:697.
113. Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer disease: The Nun Study. JAMA 1997, 277:813.
114. Esiri MM, Wilcock GK, Morris JH Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 1997, 63:749.
115. Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997, 349:151.
116. Gray F, Vinters HV, Le Noan H, et al. Cerebral amyloid angiopathy and granulomatous angiitis: Immunohistochemical study using antibodies to the Alzheimer A4 peptide. Hum Pathol 1990, 21:1290.
117. Mandybur TI, Balko G Cerebral amyloid angiopathy with granulomatous angiitis ameliorated by steroid-cytoxan treatment. Clin Neuropharmacol 1992, 15:241.
118. Fountain NB, Eberhard DA Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy: Report of two cases and review of the literature. Neurology 1996, 46:190.
119. Case records of the Massachusetts General Hospital Weekly clinicopathological exercises. Case 10-2000: A 63-year-old man with changes in behavior and ataxia [clinical conference]. N Engl J Med 2000, 342:957.
120. Fountain NB, Lopes MB Control of primary angiitis of the CNS associated with cerebral amyloid angiopathy by cyclophosphamide alone. Neurology 1999, 52:660.
121. Smith DB, Hitchcock M, Philpott PJ Cerebral amyloid angiopathy presenting as transient ischemic attacks: Case report. J Neurosurg 1985, 63:963.
122. Young WH, Robert ME, Secor DL, et al. Cerebral hemorrhage with biopsy-proved amyloid angiopathy. Arch Neurol 1992, 49:51.
123. Palsdottir A, Abrahamson M, Thorsteinsson L, et al. Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet 1988, 2(8611):603.
124. Levy E, Lobez-Otin C, Ghiso J, et al. Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases. J Exp Med 1989, 169:1771.
125. Vidal R, Frangione B, Rostagno A, et al. A stop-codon mutation in the BRI gene associated with familial British dementia. Nature 1999, 399:776.
126. Mead S, James-Galton M, Revesz T, et al. Familial British dementia with amyloid angiopathy: Early clinical, neuropsychological and imaging findings. Brain 2000, 123:975.
127. Vidal R, Garzuly F, Budka H, et al. Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at condon 18 (TTRD 18G). Am J Pathol 1996, 148:361.
128. Herrick MK, DeBruyne K, Horoupian DS, et al. Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene. Neurology 1996, 47:988.
129. Petersen RB, Goren H, Cohen M, et al. Transthyretin amyloidosis: A new mutation associated with dementia. Ann Neurol 1997, 41:307.
130. Mascalchi M, Salvi F, Pirini MG, et al. Transthyretin amyloidosis and superficial siderosis of the CNS. Neurology 1999, 53:1498.
131. Brett M, Persey MR, Reilly MM, et al. Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis. Brain 1999, 122:183.
132. Selkoe DJ The origins of Alzheimer disease: A is for amyloid. JAMA 2000, 283:1615.
133. Levy E, Carman MD, Fernandez Madrid IJ, et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990, 248:1124.
134. Van Broeckhoven C, Haan J, Bakker E, et al. Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science 1990, 248:1120.
135. Wattendorff AR, Frangione B, Luyendijk W, et al. Hereditary cerebral haemorrhage with amyloidosis, Dutch type (HCHWA-D): Clinicopathological studies. J Neurol Neurosurg Psychiatry 1995, 58:699.
136. Bornebroek M, Westendorp RG, Haan J, et al. Mortality from hereditary cerebral haemorrhage with amyloidosis-Dutch type: The impact of sex, parental transmission and year of birth. Brain 1997, 120:2243.
137. Tagliavini F, Rossi G, Padovani A, et al. A new βPP mutation related to hereditary cerebral haemorrhage. Alzheimer's Rep 1999, 2:S28.
138. Hendriks L, van Duijn CM, Cras P, et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet 1992, 1:218.
139. Cras P, van Harskamp F, Hendriks L, et al. Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala→Gly mutation. Acta Neuropathol (Berl) 1998, 96:253.
140. Graffagnino C, Herbstreith MH, Schmechel DE, et al. Cystatin C mutation in an elderly man with sporadic amyloid angiopathy and intracerebral hemorrhage. Stroke 1995, 26:2190.
141. Anders KH, Wang ZZ, Kornfeld M, et al. Giant cell arteritis in association with cerebral amyloid angiopathy: Immunohistochemical and molecular studies. Hum Pathol 1997, 28:1237.
142. Itoh Y, Yamada M Cerebral amyloid angiopathy in the elderly: The clinicopathological features, pathogenesis, and risk factors. J Med Dental Sci 1997, 44:11.
143. Nagai A, Kobayashi S, Shimode K, et al. No mutations in cystatin C gene in cerebral amyloid angiopathy with cystatin C deposition. Mol Chem Neuropathol 1998, 33:63.
144. McCarron MO, Nicoll JA, Stewart J, et al. Absence of cystatin C mutation in sporadic cerebral amyloid angiopathy- related hemorrhage. Neurology 2000, 54:242.
145. Nicoll JA, Burnett C, Love S, et al. High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1997, 41:716.
146. McCarron MO, Nicoll JAR APOE genotype in relation to sporadic and Alzheimer-related CAA. Cerebral Amyloid Angiopathy in Alzheimer's Disease and Related Disorders 2000, 81. Kluwer Academic Publishers, Dordrecht. M.M. Verbeek, M.W. de Waal, H.V. Vinters (Eds.).
147. Hemphill JC, Bonovich DC, Besmertis L, et al. The ICH score: A simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001, 32:891.
148. Alberts MJ, Graffagnino C, McClenny C, et al. APOE genotype and survival from intracerebral haemorrhage. Lancet 1995, 346:575.
149. McCarron MO, Muir KW, Weir CJ, et al. The apolipoprotein E epsilon4 allele and outcome in cerebrovascular disease. Stroke 1998, 29:1882.
150. Bailey RD, Hart RG, Benavente O, et al. Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology 2001, 56:773.
151. Broderick JP, Adams HP, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999, 30:905.
152. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997, 28:1.
153. Greene GM, Godersky JC, Biller J, et al. Surgical experience with cerebral amyloid angiopathy. Stroke 1990, 21:1545.
154. Leblanc R, Preul M, Robitaille Y, et al. Surgical considerations in cerebral amyloid angiopathy. Neurosurgery 1991, 29:712.
155. Matkovic Z, Davis S, Gonzales M, et al. Surgical risk of hemorrhage in cerebral amyloid angiopathy. Stroke 1991, 22:456.
156. Kase CS Cerebral amyloid angiopathy. Intracerebral Hemorrhage 1994, 179. Butterworth-Heinemann, Boston, . C.S. Kase, L.R. Caplan (Eds.).
157. Minakawa T, Takeuchi S, Sasaki O, et al. Surgical experience with massive lobar haemorrhage caused by cerebral amyloid angiopathy. Acta Neurochir 1995, 132:48.
158. Izumihara A, Ishihara T, Iwamoto N, et al. Postoperative outcome of 37 patients with lobar intracerebral hemorrhage related to cerebral amyloid angiopathy. Stroke 1999, 30:29.
159. Gustafsson C, Asplund K, Britton M, et al. Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective. BMJ 1992, 305:1457.
160. Eckman MH, Levine HJ, Salem DN, et al. Making decisions about antithrombotic therapy in heart disease: Decision analysis and cost-effectiveness issues. Chest 1998, 114:699S.
161. Schafer AI Antiplatelet therapy. Am J Med 1996, 101:199.
162. Riendeau D, Charleson S, Cromlish W, et al. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. Can J Physiol Pharmacol 1997, 75:1088.
163. Selkoe DJ Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999, 399:A23.
164. Games D, Adams D, Alessandrini R, et al. Alzheimer-type neuropathology in transgenic mice overexpressing v717f beta-amyloid precursor protein. Nature 1995, 373:523.